COVID-2019
Conditions
Interventions
The intervention group:a combination of conventional therapy and traditional chinese medicine treatment
Sponsors
Shenzhen Traditional Chinese Medicine Hospital
Eligibility
Sex/Gender
All
Age
14 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1) The mild and ordinary patients who meet the diagnostic criteria of COVID-19; (2) 70 years old = 14 years old; (3) did not receive other clinical studies before selection; (4) voluntarily accepted the trial and signed the informed consent form.
Exclusion criteria
Exclusion criteria: (1) pregnant and lactating women; (2) patients with delirium, dementia and various psychosis; (3) patients with chronic respiratory diseases, including chronic bronchitis, bronchial asthma, chronic obstructive pulmonary disease, bronchiectasis, pulmonary fibrosis, pulmonary tuberculosis (uncured) and so on. (4) patients with autoimmune-related diseases (psoriasis, ankylosing spondylitis, etc.) were treated with biological agents in the past month. (5) patients with known experimental drug allergy (6) patients with heart, liver and renal insufficiency before selection; (7) patients with malignant tumor, blood system disease or immune deficiency; (8) patients who were treated with glucocorticoid for a long time; (9) patients with other diseases before selection were determined to interfere with the results of clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nucleic acid detection negative time;The percentage of subjects who changed from mild to severe;a clinical symptom score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Laboratory indicators;Length of hospital stay;Chest imaging changes; | — |
Countries
Chinese
Contacts
Public ContactLiu yuxiang
Outcome results
None listed